PTSD Rapid Saliva Test for Diagnostic & Therapeutic Monitoring

Goal: Develop a rapid in-vitro test for PTSD diagnostics.

 

 

PTSD Diagnostics

PTSD is one of the most serious and highly prevalent wounds suffered by U.S. warfighters that were deployed in Iraq and Afghanistan. 33-39% of individuals with a history of mTBI will develop PTSD. Approximately 17% of active duty and 25% of reserve military personnel meet diagnostic criteria for PTSD 3-6 months post-deployment. Among veterans, the prevalence of PTSD is nearly 20%.

PTSD Project

PTSD is serious health disorder with significant costs to the individual and society. There is a major concern across VA and DoD healthcare regarding PTSD diagnostics and care. Currently, PTSD is diagnosed using examination by mental health professionals. The gold standard is the CAPS test. Many warfighters avoid getting tested because of stigma associated with mental health.

PTSD is serious health disorder with significant costs to the individual and society. There is a major concern across VA and DoD healthcare regarding PTSD diagnostics and care. Currently, PTSD is diagnosed using examination by mental health professionals. The gold standard is the CAPS test. Many warfighters avoid getting tested because of stigma associated with mental health.

Capability Gap: the lack of objective, rapid test for PTSD assessment in point-of-care settings (POC). The proposed rapid POC PTSD test will enable PTSD screening during routine health exams. This will facilitate early, objective detection, guide effective individualized treatment of PTSD, and provide objective metrics for return-to-duty decision.

 

 

 

Welcome
Welcome
first image second image third image fourth image fifth image sixth image seventh image eighth image
Welcome
themed object
Where Medical Necessity Meets Innovation